Home>IPO>Glenmark Life Sciences Ltd.

Glenmark Life Sciences IPO

Glenmark Life Sciences Ltd.

₹13,900 /20 sharesMinimum Investment

IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
27 Jul - 29 Jul ‘21₹13,90020₹695 - ₹720
Issue SizeIPO Doc
1513.6 Cr
RHP PDFopen_in_new

Subscription Rate As on 29th Jul 2021, 1:00 PM

  • Retail Individual Investor
    11.81x
  • Non-Institutional Investor
    14.02x
  • Qualified Institutional Buyers
    2.31x

About Company

Glenmark Life Sciences Ltd., a subsidiary of Glenmark Pharmaceuticals Ltd., is a leading developer and manufacturer of select high-value, non-commoditized active pharmaceutical ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. It also manufactures and sells APIs for gastro-intestinal disorders, anti-infectives, and other therapeutic areas.
... Read More
Parent Organisation
Glenmark Life Sciences Ltd.
Founded
2011
Managing Director
Yasir Rawjee
Glenmark Life Sciences IPO review - Glenmark Life Sciences IPO details, business, financials

Strengths & Risks

  • add
    Leading developer and manufacturer of select high value, non-commoditized APIs in chronic therapeutic areas
  • add
    Strong relationships with leading global generic pharmaceutical companies
  • add
    Quality-focused and has compliant manufacturing and R&D infrastructure
  • add
    Focused on sustainability in its operations through meaningful interventions in environment management, safety initiatives in its operations, and the occupational health of its workforce.
  • add
    Glenmark strives to achieve cost leadership across many of its products through the careful application of operations initiatives, sourcing initiatives, and R&D initiatives
  • add
    Experienced Promoters with a strong management team
  • remove
    Regulatory action due to a manufacturing or quality control problem
  • remove
    Dependency on a limited number of key customers for a significant portion of its revenues
  • remove
    Generates a significant portion of its total revenue from its API business from the sale of products in a limited number of principal therapeutic categories
  • remove
    Manufacturing and R&D facilities are located in two states and any disruption in these states can cause manufacturing to stop
  • remove
    Delay, interruption, or reduction in the supply of raw materials can harm operations
  • remove
    Impact of COVID-19
  • remove
    Significant working capital requirements for its manufacturing operations and development of new products
  • remove
    The brand name ‘Glenmark’ and the trademarks for the name ‘Glenmark Life Sciences’ and logo are registered in the name of the promoter of the company
  • remove
    Impact of pricing pressure from customers on gross margin, profitability and the company’s ability to increase the prices
  • remove
    The company has to obtain and maintain a number of statutory and regulatory licenses, permits and approvals for carrying out business including consents to establish and operate under environmental laws
  • remove
    Exposure to counterparty credit risk
  • remove
    Inability to accurately forecast demand for its products and manage inventory accordingly

Financials

*All values are in Rs. Cr
No Graph Data To Display

Top IPO FAQs

What is the Glenmark Life Science IPO?

keyboard_arrow_down
The issue size of the Glenmark Life Science IPO is Rs 1,513.6 crores.

What is 'pre-apply for Glenmark Life Sciences Ltd. IPO'?

keyboard_arrow_down
Pre-apply will alow you to apply for the Glenmark IPO 3-4 days before the subscription period starts. Glenmark IPO is open for subscription between July 27 and 29.

If I pre-apply for Glenmark Life Sciences Ltd. IPO, when will my order get placed?

keyboard_arrow_down
Your order will be placed on the exchange as soon as the Glenmark IPO bidding starts. You will receive a UPI request within 24 hours after the bidding period opens.

When will I know if my Glenmark Life Sciences Ltd. IPO order is placed?

keyboard_arrow_down
We will notify you when your Glenmark IPO order is placed with the exchange.

How is Glenmark Life Science Limited associated with Glenmark Pharmaceuticals Limited?

keyboard_arrow_down
Glenmark Pharmaceuticals Limited is the parent company that owns Glenmark Life Science Limited.

What are the open and close dates of the Glenmark Life Science IPO?

keyboard_arrow_down
Glenmark Life Sciences IPO date is scheduled to open on July 27, 2021 and the last date for applications is July 29, 2021.

What is the lot size and minimum order quantity of the Glenmark Life Science IPO?

keyboard_arrow_down
Glenmark Life Science IPO price band is Rs 695 to 720 per share and the lot size is 20 shares.

What are the allotment dates for the Glenmark Life Science IPO?

keyboard_arrow_down
Glenmark Life Science IPO allotment date is expected to be on August 03, 2021.

Who is the registrar of Glenmark Life Science IPO?

keyboard_arrow_down
KFin Technologies Private Limited

Where is the Glenmark Life Science IPO getting listed?

keyboard_arrow_down
The shares are proposed to be listed on the BSE and NSE.
ⓒ 2016-2021 Groww. All rights reserved, Built with in India
ABOUT GROWW
keyboard_arrow_down